Science start-ups drive demand for life-science hubs

Life sciences companies have been growing at pace since the pandemic put the industry in the spotlight. Ageing populations, technological advances, and rapid innovation in new fields such as weight loss and anti-body drugs are driving expansion.

The number of newly-formed life sciences companies – including biotech, health technologies and pharma start-ups – is up more than 13% in the past five years.

As a result, more specialized lab space is required, but in European life science clusters, it’s not so readily available, with vacancy in multi-occupancy lab and incubator spaces extremely tight. In the U.S., lab demand rose by over 6% in the first quarter of 2024, with quarterly growth for lab space in Boston, the Bay Area and San Diego averaging 17% in recent months.

“Competition for lab space is being fuelled by the fact that many established pharma companies are now outsourcing elements of research under contract to these smaller firms” says Suketu Shah Head of UK Life Sciences Property Management for JLL.

Commercial real estate investors are taking note. They now rank life sciences second on a list of sectors that provide the greatest opportunity, up from 17^th pre-pandemic, according to JLL’s 2024 Investor survey. And as the need for flexible space rises, a new generation of multi-tenant hubs is emerging, particularly in the most mature life science clusters.

Take the 100,000 sq. ft life sciences, technology and innovation space planned on the site of a former Debenhams in the heart of Oxford. The site will provide a much needed, high specification solution to the requirements of the city’s fast-growing science, technology and innovation sectors.

In Dublin, Pioneer Group’s Cherrywood campus caters for companies at the early stages of incubation, with space for over 100 life science and health technology professionals, entrepreneurs, and researchers.

Drug discovery is an expensive business

With budgets at new life science companies tight, and the cost of specialist equipment high, smaller firms are seeking to avoid large upfront capital outlay.

Enter ‘easy-in, easy-out’ multi-tenant hubs and incubator spaces, which give them shared access to the kit they need, with the cost covered by rental premiums or service charges.

“It reduces risk by allowing smaller firms and start-ups to channel their limited funds into core research,” says Shah. “Regular lease breaks also mean they can easily scale up - if and when they secure the next round of funding.”

The conversion of the iconic Victoria House in London’s Bloomsbury Square will cater for this scenario by offering the option to upgrade to dedicated space with premium equipment, a boon for growing companies.